TREVISAN DOS SANTOS, GABRIELA
 Distribuzione geografica
Continente #
EU - Europa 902
NA - Nord America 833
AS - Asia 131
Totale 1.866
Nazione #
US - Stati Uniti d'America 830
PL - Polonia 654
IT - Italia 74
IE - Irlanda 69
CN - Cina 43
SE - Svezia 39
HK - Hong Kong 35
RU - Federazione Russa 30
SG - Singapore 20
VN - Vietnam 16
JO - Giordania 12
DE - Germania 9
FI - Finlandia 9
GB - Regno Unito 6
BE - Belgio 4
CA - Canada 3
CH - Svizzera 2
ES - Italia 2
KR - Corea 2
UA - Ucraina 2
GR - Grecia 1
IN - India 1
JP - Giappone 1
NL - Olanda 1
TR - Turchia 1
Totale 1.866
Città #
Warsaw 652
Fairfield 166
Woodbridge 77
Ashburn 70
Dublin 69
Seattle 61
Cambridge 59
Chandler 56
Houston 50
Wilmington 46
Ann Arbor 36
Lawrence 28
Altamura 26
Hong Kong 24
Florence 18
Princeton 17
Beijing 16
Dong Ket 14
Singapore 14
Medford 11
Shanghai 11
Boston 9
Buffalo 8
Boardman 7
Phoenix 7
Moscow 6
Bremen 5
Dearborn 5
Brussels 4
Kent 4
Milan 4
New York 4
Redwood City 4
Fiesole 3
Guangzhou 3
Jacksonville 3
Norwalk 3
San Diego 3
Barcelona 2
Bern 2
Castelliri 2
Hillsboro 2
Kunming 2
Padova 2
Querceta 2
Tappahannock 2
Toronto 2
Vicenza 2
Andover 1
Falls Church 1
Fuzhou 1
Helsinki 1
Islington 1
Izmir 1
Jinan 1
Kilburn 1
Lappeenranta 1
London 1
Los Angeles 1
Montréal 1
Nanjing 1
Ningbo 1
Oppido Lucano 1
Portland 1
Rimini 1
Rui'an 1
Saletto 1
Seongnam 1
Seoul 1
Vigevano 1
Totale 1.645
Nome #
TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress 277
Novel Therapeutic Strategy to Prevent Chemotherapy-Induced Persistent Sensory Neuropathy By TRPA1 Blockade 230
Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice 221
Transient receptor potential ankyrin 1 receptor stimulation by hydrogen peroxide is critical to trigger pain during monosodium urate-induced inflammation in rodents 152
Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain 144
Topical treatment with a transient receptor potential ankyrin 1 (TRPA1) antagonist reduced nociception and inflammation in a thermal lesion model in rats 136
Dacarbazine alone or associated with melanoma-bearing cancer pain model induces painful hypersensitivity by TRPA1 activation in mice 123
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 105
TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout. 103
Macrophages and Schwann cell TRPA1 mediate chronic allodynia in a mouse model of complex regional pain syndrome type I 96
Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel 95
Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1 77
Periorbital nociception in a progressive multiple sclerosis mouse model is dependent on trpa1 channel activation 41
TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger pain during MSU-induced inflammation. 37
Peripheral nerve resident macrophages and schwann cells mediate cancer-induced pain A C 37
Transient receptor potential ankyrin 1 mediates headache-related cephalic allodynia in a mouse model of relapsing-remitting multiple sclerosis 32
Unpredictable Sound Stress Model Causes Migraine-Like Behaviors in Mice With Sexual Dimorphism 13
Neuropathic-like Nociception and Spinal Cord Neuroinflammation Are Dependent on the TRPA1 Channel in Multiple Sclerosis Models in Mice 4
Totale 1.923
Categoria #
all - tutte 5.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020488 0 50 16 38 68 51 56 63 47 46 44 9
2020/2021358 30 48 6 56 21 28 23 26 26 64 8 22
2021/2022140 13 10 14 7 1 3 7 6 10 13 21 35
2022/2023319 24 67 26 22 12 55 43 10 37 2 15 6
2023/2024114 4 13 16 5 9 6 4 30 4 7 8 8
2024/202551 42 9 0 0 0 0 0 0 0 0 0 0
Totale 1.923